SCHEMBL30425664

SCHEMBL30425664

COc1cc(/C=C/C(=O)O)ccc1O[Si](C)(C)C

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.77
ALDH1A1 P00352 3/20 0.77
HPGD P15428 2/20 0.77
HSD17B10 Q99714 2/20 0.77
ALOX15 P16050 1/20 0.77
MAPK1 P28482 1/20 0.77
SMN1; SMN2 Q16637 1/20 0.77
SNCA P37840 2/20 0.64
PKM P14618 2/20 0.64
CA12 O43570 1/20 0.64
CA1 P00915 1/20 0.64
CA2 P00918 1/20 0.64
CA3 P07451 1/20 0.64
CSNK2A2 P19784 1/20 0.64
CA4 P22748 1/20 0.64
CA6 P23280 1/20 0.64
CA5A P35218 1/20 0.64
CA7 P43166 1/20 0.64
CSNK2B P67870 1/20 0.64
CSNK2A1 P68400 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
O,O'-Dimethylcaffeic Acid SCHEMBL81318 0.88 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10ALOX15
O,O'-Dimethylcaffeic Acid SCHEMBL81317 0.88 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10ALOX15
O,O'-Dimethylcaffeic Acid SCHEMBL29636389 0.88 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL30448694 0.87 KDM4E (0.57) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL2553992 0.86 KDM4E (0.69) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL2553988 0.86 KDM4E (0.69) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL30656553 0.86 KDM4E (0.69) KDM4EALDH1A1HPGDHSD17B10ALOX15
O,O'-Dimethylcaffeic Acid SCHEMBL28025225 0.86 KDM4E (0.97) KDM4EALDH1A1HPGDHSD17B10ALOX15
O,O'-Dimethylcaffeic Acid SCHEMBL27858763 0.86 KDM4E (0.97) KDM4EALDH1A1HPGDHSD17B10ALOX15
O,O'-Dimethylcaffeic Acid SCHEMBL27858762 0.86 KDM4E (0.97) KDM4EALDH1A1HPGDHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11643428-B2 Therapeutic drug for neurodegenerative disease and application thereof SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2023-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11643428-B2 Therapeutic drug for neurodegenerative disease and application thereof NES, GAP43, NLN KDM4E 3114/4885ALDH1A1 202/4885HPGD 331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.